A Lipid-Structured Model of Atherosclerotic Plaque Macrophages with Lipid-Dependent Kinetics
M. G. Watson, K. L. Chambers, M. R. Myerscough

TL;DR
This paper introduces a lipid-dependent macrophage model for atherosclerotic plaques, revealing how lipid-related behaviors influence plaque development and composition, advancing understanding of plaque progression mechanisms.
Contribution
The study develops a novel partial-integro differential equation model incorporating lipid-dependent macrophage behaviors, extending previous models to better understand plaque dynamics.
Findings
Lipid-dependent macrophage behaviors significantly impact plaque composition.
Different lipid-dependent processes can lead to similar overall outcomes.
Model suggests potential targets for therapeutic intervention.
Abstract
Atherosclerotic plaques are fatty growths in artery walls that cause heart attacks and strokes. Plaque formation is orchestrated by macrophages that are recruited to the artery wall to consume and remove blood-derived lipids, such as low-density lipoprotein (LDL). Ineffective lipid removal, due to macrophage death and other factors, leads to the accumulation of lipid-loaded macrophages and formation of a necrotic core. Experimental observations suggest that macrophage functionality varies with the extent of lipid loading. However, little is known about the resultant influence on plaque fate. Extending work by Ford et al. (2019) and Chambers et al. (2022), we develop a plaque model in which macrophages are classified by their ingested lipid content and behave in a lipid-dependent manner. The model, a system of partial-integro differential equations, considers several macrophage…
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsAdipokines, Inflammation, and Metabolic Diseases · Immune cells in cancer
